(Q40492547)

English

Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Keita Ebisu

3

0 references

object named as

Michael Reiss

12

0 references

author name string

Maysa M Abu-Khalaf

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Stephen Windsor

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Saritha Salikooti

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gowri Ananthanarayanan

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Gina G Chung

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Michael P DiGiovanna

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bruce G Haffty

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Martin Abrams

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Leonard R Farber

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Arlene D Hsu

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Daniel Zelterman

13

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Barbara A Burtness

14

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

69

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

372-383

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1159%2F000089991

21 January 2018

Identifiers

10.1159/000089991

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40492547&oldid=1898145300"